Enrollment opens for an Ophthalmology trial in Russia

We are excited to announce the enrollment launch for the Phase III study in patients with ocular hypertension or primary open-angle glaucoma.

This ophthalmology study is multicentre, investigator-masked, and cross-over. Being a non-inferiority and a comparative trial, it aims to evaluate the efficacy and tolerability of an eye drop solution used to treat increased pressure inside the eye.

Global Clinical Trials is responsible for local project management, regulatory services, site management, and logistics services.

Pictured: a diagram showing the visual field in a patient with glaucoma, measured by a campimeter. Image credit: Pignol23, under CC BY-SA 3.0

Subscribe to our mailing list

Marketing Permissions

Please select all the ways you would like to hear from Global Clinical Trials (GCT):

You can unsubscribe at any time by clicking the link in the footer of our emails. Please see our Privacy Policy. We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.

About

GCT is a CRO experienced in performing clinical research in the USA, Europe, Russia and India.

We are a full-service clinical development provider, offering feasibility analysis, regulatory submission, site selection, project management, monitoring, data management, logistics, and more.

Go social with us

Follow us on social networks:

Privacy policy, Terms of service, Site map, Employees login

 

GCT

© 2001—2019 Global Clinical Trials, LLC

All rights reserved.